Oral Proteins & Peptides Market to Grow with a CAGR of 12.10% through 2028
Rising prevalence of chronic diseases, technological
advancements, and patient-centric approaches to treatment are expected to drive
the Global Oral Proteins & Peptides Market growth in the forecast period,
2024-2028.
According to TechSci Research report, “Oral
Proteins & Peptides Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2028”, the Global Oral
Proteins & Peptides Market stood at USD 1.33 billion in 2022 and is
anticipated to grow with a CAGR of 12.10% in the forecast period, 2024-2028.
This can be attributed to market expansion beyond therapeutics. The growth
potential of oral proteins and peptides extends beyond therapeutic
applications. Nutraceuticals and dietary supplements containing these molecules
are gaining popularity among health-conscious consumers. These products promise
various health benefits, contributing to the diversification of the market.
Furthermore, oral proteins and peptides are finding
new applications beyond their traditional uses. Ongoing research is exploring
their potential in treating a broader range of diseases, including rare genetic
disorders, autoimmune diseases, and various cancers.
The projected growth of the Oral Proteins And Peptides
Market is underpinned by a range of critical factors. These include the
increasing prevalence of chronic diseases, a rising global geriatric
population, a preference among consumers for oral medications, growing demand
for effective treatments and advanced technology, heightened collaboration
among pharmaceutical companies, and substantial investments in healthcare
infrastructure development.
Moreover, the expansion of the market is anticipated
due to greater consumer purchasing power and heightened research and
development efforts within the pharmaceutical sector. Nevertheless, challenges
persist, including drug shortages, supply chain issues, and delays in clinical
trials for non-COVID-19 therapies, particularly in areas such as oncology and
metabolic disorders. Additionally, obstacles like high development costs,
limited product availability, lack of awareness in emerging economies, and limited
oral protein and peptide absorption may impede market growth in the short term.
However, ongoing advancements and expanding research
and development activities are expected to address these challenges, paving the
way for profitable growth in the Oral Proteins And Peptides Market in the years
to come.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Oral Proteins & Peptides Market.”
The Global Oral Proteins & Peptides Market is
segmented into drug type, application, regional distribution, and company.
Based on its drug type, Plecanatide drug type is
expected to surge within the Global Oral Proteins & Peptides Market can be
attributed to several key factors. Firstly, Plecanatide has exhibited
remarkable efficacy in the treatment of chronic idiopathic constipation (CIC)
and irritable bowel syndrome with constipation (IBS-C), addressing a
substantial unmet medical need. Moreover, its oral administration route offers
a convenient alternative to traditional injectable protein therapies, enhancing
patient compliance. Additionally, ongoing research and development efforts,
including potential label expansions for Plecanatide, are poised to further
bolster its market penetration. As healthcare providers and patients
increasingly recognize the therapeutic benefits of this drug, coupled with
growing awareness of gastrointestinal disorders, Plecanatide is expected to
witness a significant rise in demand, propelling its prominence in the global
oral proteins and peptides sector.
Based on region, the North American region is poised
for a significant upturn in the forecast of the Global Oral Proteins &
Peptides Market in 2022 for several compelling reasons. First and foremost,
North America boasts a robust healthcare infrastructure and a well-established
pharmaceutical industry, fostering an environment conducive to the development
and commercialization of oral protein and peptide-based therapies.
Additionally, a heightened focus on research and innovation, coupled with
substantial investments in biotechnology and pharmaceutical companies, has led
to the emergence of cutting-edge oral protein and peptide drug candidates
specifically tailored to address various medical conditions. Furthermore, a
growing patient population, along with increasing awareness and acceptance of
these innovative treatments, is expected to drive substantial demand in the
region. As regulatory agencies continue to streamline approval processes and as
healthcare providers increasingly integrate these therapies into their
treatment protocols, North America is primed to experience a noteworthy surge
in its share of the Global Oral Proteins & Peptides Market.
Major companies operating in Global Oral Proteins
& Peptides Market are:
- AbbVie Inc.
- Merck & Co Inc
- Pfizer Inc
- Novo Nordisk A/S
- Hoffmann-La Roche Inc
- Sanofi SA
- AstraZeneca PLC
- Bristol-Myers Squibb Co
- Tarsa Therapeutics Inc
- Novartis AG
Download Free Sample Report
Customers can also request for 10% free customization
on this report.
“The Global Oral Proteins & Peptides Market is
poised for a dynamic future characterized by innovation and patient-centric
solutions. As personalized medicine, nanotechnology, artificial intelligence,
and other trends continue to shape the landscape, patients can look forward to
more effective and convenient treatment options. These trends reflect the
industry's commitment to improving healthcare outcomes and advancing the field
of oral protein and peptide therapies. As the market evolves, it will be
important to stay attuned to these trends and developments to harness the full
potential of this exciting field,” said Mr. Karan Chechi, Research Director
with TechSci Research, a research-based management consulting firm.
“Oral Proteins & Peptides Market By Drug
Type (Calcitonin, Insulin, Linaclotide, Octreotide, Plecanatide), By
Application (Bone Diseases, Diabetes, Gastric & Digestive Disorders,
Hormonal Disorders), By Region, By
Competition Forecast & Opportunities, 2018-2028F”, has evaluated
the future growth potential of Global Oral Proteins & Peptides Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Oral Proteins & Peptides Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com